市场调查报告书
商品编码
1273559
到 2028 年的神经血管导管市场预测——按类型(血栓切除术导管、微导管、球囊导管、栓塞导管、通路导管、其他类型)、按应用、按最终用户、按地区分类的全球分析Neurovascular Catheters Market Forecasts to 2028 - Global Analysis By Type (Thrombectomy Catheters, Microcatheters, Balloon Catheters, Embolization Catheters, Access Catheters and Other Types), Application, End User and By Geography |
根据 Stratistics MRC 的数据,2022 年全球神经血管导管市场规模将达到 33 亿美元,预计到 2028 年将达到 58 亿美元,预测期内增长 9.8%。预计将以復合年增长率增长。
神经血管导管还可用于将神经血管装置输送到大脑等神经血管器官。 因此,神经血管导管被用于许多颅脑手术。 由于神经手术的大量增加,神经血管导管的使用逐渐增加。 此外,在治疗缺血性中风方面也取得了许多进展,例如正在帮助导管行业的再通道支架和支架回收器。
美国疾病控制与预防中心估计,美国每年约有 795,000 人中风。
神经血管导管与其他神经血管装置一起用于治疗中风。 因此,神经血管导管已在各种颅内手术中得到应用。 神经外科手术数量显着增加,神经血管导管的消耗量逐渐增加。 此外,采用符合人体工程学设计和提高临床效率的先进导管的推出正在推动市场的增长。
儘管中风和出血的频率越来越高,并且患有神经血管疾病的患者越来越多,但仍有一些限制阻碍了神经血管导管的广泛采用。 这是由于神经血管导管的高成本和不利的报销政策。 因此,在这些国家接受治疗的患者和使用导管的人数减少。
从开放手术到微创手术的转变对于开髮用于许多应用的先进神经血管导管至关重要。 中风发病率的上升、神经系统疾病的流行以及医疗保健专业人员对微创手术的偏好增加了发达国家和发展中国家对这些导管的需求。
与使用导管相关的程序问题给市场带来了一些挑战。 限制市场对神经血管导管需求的主要因素之一是导管阻塞的风险、导管脱落以及与神经血管器官的生物相容性。 此外,严格的监管也阻碍了市场的扩张。
随着受影响人数的增加,对医疗用品的需求也越来越大。 雾化器、生命支持设备、制氧机和监护仪等呼吸支持设备是一线临床实践中使用的医疗设备的典型示例。 此外,COVID-19 显着增加了对口罩、手套和防护眼镜等医疗用品的需求。 由于世界上越来越多的病例,不仅医疗专业人员而且普通消费者对医疗用品的需求也在不断增加。
由于急性缺血性中风的患病率上升,估计微导管部分的增长利润丰厚。 在神经血管治疗中,它是一个放入血管中的小空心管。 这些先进的导管具有多种特性,包括亲水涂层、柔软性、可跟踪性和稳定性。 该细分市场的扩张预计将受到主要市场进入者在不久的将来使用的增长技术的增加,例如产品发布。
由于手术时间的减少和微创手术技术的进步,门诊手术中心部分预计在预测期内将以最快的复合年增长率增长。 与医院相比,我们可以为患者提供很多好处,比如缩短手术时间,当天出院。 它也比医院便宜,因此患者可以节省很多钱。 这些因素促成了其快速增长。
由于疾病覆盖范围扩大、技术进步和神经系统疾病患病率增加等因素,亚太地区预计在预测期内将占据最大的市场份额。 该地区缺血、脑动脉瘤和动静脉畸形等神经血管疾病发病率的增加是导致这一上升的原因之一。 此外,该地区的增长是由该地区重要参与者的存在和不断增加的医疗保健成本推动的。
由于对神经血管疾病的认识不断提高、对微创手术的关注度不断提高以及先进导管的广泛采用,预计欧洲在预测期内的复合年增长率最高。 此外,政府活动的增加和公司研发支出的增加极大地推动了该地区的市场扩张。
2021 年 9 月,Medtronic PLC 获得了 Rist 079 径向通路指南和 Rist 径向通路选择性导管的 CE 批准。 它旨在解决通过桡动脉进行神经血管通路的需求。
2021 年 6 月,Penumbra 将以优化的可跟踪性推出,以导航大脑復杂的远端血管解剖结构,并提供强大的抽吸以清除血块。我们设计的 RED 62 导管已获得美国 FDA 批准。
订阅此报告的客户将获得以下免费定制选项之一。
According to Stratistics MRC, the Global Neurovascular Catheters Market is accounted for $3.3 billion in 2022 and is expected to reach $5.8 billion by 2028 growing at a CAGR of 9.8% during the forecast period. Neurovascular catheters are also useful for delivering neurovascular devices to neurovascular organs, such as the brain. The use of neurovascular catheters in numerous cranial surgeries is a result. The use of neurovascular catheters has gradually increased as a result of a considerable increase in neurological procedures. Additionally, there have been a number of advancements in the treatment of ischemic stroke, including flow-rerouting stents and stent retrievers that are assisting in the catheter industry.
According to the estimations of Centers for Disease Control and Prevention, around 795,000 people in the U.S. suffer from a stroke each year.
Along with other neurovascular devices, neurovascular catheters are utilised in the treatment of strokes. Consequently, neurovascular catheters are applied in various cranial procedures. There has been a significant rise in the number of neurological procedures gradually increasing the consumption of neurovascular catheters. Also, introduction of advanced catheters with ergonomic designs and improved clinical efficiency is fueling the market growth.
Despite an increase in the frequency of strokes and haemorrhages as well as a sizable patient population suffering from neurovascular illnesses, there are some limitations that are preventing the widespread use of neurovascular catheters. This is brought on by the procedures' high cost and the unfavourable reimbursement policies. As a result, there are fewer patients receiving therapy and fewer catheters are being used in these nations.
The transition from open surgery to minimally invasive surgery has been crucial in the development of sophisticated neurovascular catheters for many uses. The demand for these catheters is rising in both developed and developing nations due to the rising incidence of stroke and the prevalence of neurological illnesses as well as the preference of healthcare providers for less invasive surgeries.
The procedural concerns connected to the use of these catheters provide certain difficulties for the market. One of the main factors restricting the demand for neurovascular catheters in the market is the risk of catheter blockage, coating removal from the catheter, and its biocompatibility with neurovascular organs. Furthermore, strict rules are also preventing the market from expanding.
Medical supplies are increasingly in demand as a result of the afflicted population. Among the most common medical devices used in first-line clinical care are respiratory support devices such atomizers, life support machines, oxygen generators, and monitors. Additionally, COVID-19 has caused a significant increase in demand for medical goods such masks, gloves, and protective eyewear. The demand for medical goods is continuously increasing from both healthcare professionals and the general public as a result of an increase in instances around the world.
The microcatheters segment is estimated to have a lucrative growth, due to the rising prevalence of acute ischemic stroke. For neurovascular treatments, they are tiny, hollow tubes that are placed into blood vessels. These advanced catheters are made with a variety of features, including a hydrophilic coating, softness, trackability, and stability. The segment's expansion will be fueled in the near future by an increase in the number of growth methods used by major market participants, such as product launches.
The ambulatory surgical centers segment is anticipated to witness the fastest CAGR growth during the forecast period, due to shorter procedure time and advancements in minimally invasive surgical techniques. In comparison to hospitals, they provide patients with a number of benefits, including as faster operation times and same-day discharge. Patients can save a lot of money by using them because they can be less expensive than hospitals. These factors have contributed to its rapid growth.
Asia Pacific is projected to hold the largest market share during the forecast period owing to the factors such as rising target disease burden, technological advancements, increasing prevalence of neurological disorders. The increasing incidence of neurovascular illnesses in this region, such as ischemia, brain aneurysms, and arteriovenous malformations, is one reason contributing to this rise. Additionally, the region's growth is being aided by the presence of important players in the area and growing healthcare costs.
Europe is projected to have the highest CAGR over the forecast period, owing to the rising awareness about the neurovascular disorders, the increasing focus on minimally invasive surgeries, and high adoption of advanced catheters. The expansion of the regional market is also being considerably aided by greater government activities as well as increasing R&D spending by businesses.
Some of the key players profiled in the Neurovascular Catheters Market include: Integra Holdings Corporation, Stryker, Concentric Medical, Inc., Medtronic, Johnson and Johnson company, Zeus Industrial Products, Acandis GmbH, Terumo Corporation, Penumbra, Inc., Biomerics, Creganna Medical, Microvention Inc. and DePuy Synthes.
In September 2021, Medtronic PLC received CE approval for Rist 079 Radial Access Guide and Rist Radial Access Selective Catheter. It aims to cater the needs of accessing neuro vasculature through the radial artery.
In June 2021, Penumbra received US FDA Clearance for its RED 62 catheters, designed with optimized trackability to help navigate the complex distal vessel anatomy in the brain and deliver powerful aspiration for the removal of blood clots.
All the customers of this report will be entitled to receive one of the following free customization options: